PRILOSEC OTC (omeprazole magnesium) by AstraZeneca is compounds, the substituted benzimidazoles, that suppress gastric acid secretion by specific inhibition of the h/k atpase enzyme system at the secretory surface of the gastric parietal cell. First approved in 2003.
Drug data last refreshed 2d ago
compounds, the substituted benzimidazoles, that suppress gastric acid secretion by specific inhibition of the H/K ATPase enzyme system at the secretory surface of the gastric parietal cell. Because this enzyme system is regarded as the acid (proton) pump within the gastric mucosa, omeprazole has…
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Esomeprazole Magnesium Dihydrate 40 mg Tablets Relative to Nexium 40 mg Tablets Under Fed Condition
Esomeprazole Magnesium Dihydrate 40 mg Tablets Relative to Nexium 40 mg Tablets Under Fasting Condition
Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC
A Pharmacodynamic Study Comparing Zegerid® and Prilosec OTC® (Study CL2008-02)(P07814)(COMPLETED)
A Pharmacodynamic Study Comparing Zegerid® and Prilosec OTC® (CL2007-17 )(P07813)(COMPLETED)
Worked on PRILOSEC OTC at AstraZeneca? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.